Showing results (101-110 of 459) with videos related to
Sort By:
Pageof 46
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Special issues in clinical trials of new anti-infective drugs for the treatment of sexually transmitted diseases. Infectious Diseases Society of America and the Food and Drug AdministrationH H Handsfield, J A McCutchan, L Corey, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of genital infections due to herpes simplex virus. Infectious Diseases Society of America and the Food and Drug AdministrationL Corey, J A McCutchan, A R Ronald, et al.Annals of Internal Medicine|October 15, 1994
NIH conference. HIV vaccine development: a progress reportD F Hoth, D P Bolognesi, L Corey, et al.Archives of Virology|January 5, 2002
Inhibition of apoptosis by primary isolates of herpes simplex virusK R Jerome, R Fox, Z Chen, et al.Journal of Clinical Microbiology|April 1, 1988
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human seraR L Ashley, J Militoni, F Lee, et al.Annals of Internal Medicine|August 1, 1976
Serum neutralizing antibody after rabies postexposure prophylaxisL Corey, M A Hattwick, G M Baer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of chancroid. Infectious Diseases Society of America and the Food and Drug AdministrationA R Ronald, L Corey, J A McCutchan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of sexually transmitted chlamydial infections and related clinical syndromes. Infectious Diseases Society of America and the Food and Drug AdministrationH H Handsfield, A R Ronald, L Corey, et al.Blood|July 27, 2001
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcomeW G Nichols, L Corey, T Gooley, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantationF Crippa, L Corey, E L Chuang, et al.Pageof 46